Lisdexamfetamine dimesylate in binge eating disorder: a placebo controlled trial

ConclusionLisdexamfetamine dimesylate may have clinical utility for BED but further studies of its efficacy, tolerability, and safety in this population are needed. Copyright © 2016 John Wiley & Sons, Ltd.

Source: Human Psychopharmacology: Clinical and Experimental - September 19, 2016 Category: Psychiatry Authors: Anna I. Guerdjikova, Nicole Mori, Thomas J. Blom, Paul E. Keck, Stephanie L. Williams, Jeffrey A. Welge, Susan L. McElroy Tags: Research Article Source Type: research